Effect of experimental obesity and subsequent weight reduction upon circulating atrial natriuretic peptide.
The effect of obesity and weight reduction upon circulating concentrations of atrial natriuretic peptide was assessed in an experimental model of the disease. Obese rats weighing in excess of 750 g were compared with formerly obese animals subjected to a 15-week period of caloric restriction resulting in a 40% reduction in body weight. Mean adipocyte size was significantly reduced with weight loss, as was estimated body fat. Mean arterial blood pressure remained normotensive for both groups, but a significant reduction in heart rate was associated with weight reduction. Circulating atrial natriuretic peptide was significantly elevated in the lean rats, which also exhibited decreased plasma renin activity and a negative sodium balance. Analysis of heart to body weight ratios implied that an obesity-associated, volume-induced cardiac hypertrophy remained even after the normalization of body fat. These results suggest that the diuresis and natriuresis accompanying weight reduction may be facilitated by atrial natriuretic peptide, which was elevated in part due to a persistent left ventricular hypertrophy following the transition from the obese to lean condition.
Crandall
D L
DL
Department of Cardiovascular Biological Research, American Cyanamid Company Medical Research Division, Lederle Laboratories, Pearl River, New York 10965.
Ferraro
G D
GD
Cervoni
P
P
D000273:Adipose Tissue / Q000033:anatomy & histology / Q000502:physiology; D000818:Animals; D009320:Atrial Natriuretic Factor / Q000097:blood*; D006321:Heart / Q000033:anatomy & histology; D006439:Hemodynamics; D007668:Kidney / Q000502:physiology / Q000503:physiopathology; D009765:Obesity / Q000097:blood* / Q000503:physiopathology; D051381:Rats; D015431:Weight Loss
D009320:Atrial Natriuretic Factor